Category: Forbes

A.I. Cancer Technology Gets The Green Light In England

Demand for healthcare, including cancer treatment, is already high and expected to grow as the population ages. Tools like AI may help the public health system keep up.

What We Know About ‘Eris’ Covid Variant EG.5: The Dominant Stain Driving An Uptick In Cases

“Eris” makes up 17% of all cases in the U.S., but its symptoms aren’t believed to be more severe than earlier variants.

Suicide Rate Reaches All-Time High In 2022, CDC Data Suggests

Death by suicide in the U.S. increased by 2.6% between 2021 and 2022, according to provisional data from the CDC.

Kim Kardashian Promotes $2,500 Body Scan—Here’s What To Know And Why Some Experts Warn Against It

Some experts caution against the scans—brought into the mainstream by celebrities like Kardashian—as they say it’s a waste of healthcare resources and money.

New Study Shows How AI Can Help Detect Breast Cancer

Artificial intelligence may help mammograms detect more breast cancer

New Study Shows How AI Can Help Detect Breast Cancer

Artificial intelligence may help mammograms detect more breast cancer

Amazon Clinic Expands Nationwide. Will It Get Us To A New Patient-Centric Healthcare Delivery Model?

Amazon has a long track record of disruption, and this latest move demonstrates that a more convenient, accessible, affordable, transparent healthcare model is possible.

Cat Coronavirus Outbreak: Thousands Of Felines Die In Cyprus As Vets Turn To Human Drug For Treatment

An animal activist group estimates the virus has killed some 300,000 cats since January.

The Critical Fix We Need To Rebuild Our Broken Antibiotic Pipeline

Superbug infections kill more people now than HIV/AIDS or malaria. We need new antibiotics and other drugs, but developers lack incentives. A new policy could fix that.

Wegovy Shortage: Supplies Of Weight-Loss Drug Remain Restricted Amid Booming Sales

Novo Nordisk, which also sells diabetes drug Ozempic, said it is working to build capacity but expects periodic supply constraints for the near future.